Puma Biotechnology, Inc. (PBYI)

Puma Biotechnology Revenue

Puma Biotechnology had revenue of $47.08M in the quarter ending June 30, 2024, a decrease of -13.72%. This brings the company's revenue in the last twelve months to $219.14M, down -4.77% year-over-year. In the year 2023, Puma Biotechnology had annual revenue of $235.64M with 3.34% growth.

• Revenue (ttm): $219.14M
• Revenue Growth: -4.77%
• P/S Ratio: 0.61
• Revenue / Employee: $1,184,557
• Employees: 185
• Market Cap: 136.84M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	235.64M	7.61M	3.34%
Dec 31, 2022	228.03M	-25.12M	-9.92%
Dec 31, 2021	253.16M	28.05M	12.46%
Dec 31, 2020	225.11M	-47.15M	-17.32%
Dec 31, 2019	272.26M	21.27M	8.47%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.